Avci, Ali Berkant
Feist, Eugen
Burmester, Gerd R.
Funding for this research was provided by:
Charité - Universitätsmedizin Berlin
Article History
Accepted: 18 October 2023
First Online: 21 November 2023
Declarations
:
: No sources of funding were used to support the writing of this article.
: Ali Berkant Avci has no conflicts of interest that are directly relevant to the content of this article. Eugen Feist has received honoraria for lectures as an advisor from AbbVie, BMS, Celgene, Galapagos, Lilly, Medac, Novartis, Pfizer, Sobi, and Sanofi. Gerd R. Burmester has received honoraria for consulting and lectures from Chugai and Sanofi.
: Not applicable.
: Not applicable.
: Not applicable.
: This article has no associated data.
: Not applicable.
: The authors have contributed sufficiently to the article (drafting and/or critical revision of the manuscript and approved the final submitted version of the manuscript) and share collective responsibility and accountability for the article.